Walgreens Boots Alliance Inc. participates in a fraudulent scheme to inflate generic drug prices and overcharge patients, a new proposed class action alleges (Grabstald v. Walgreens Boots All., Inc., N.D. Ill., No. 1:17-cv-05789, complaint filed 8/9/17).
The lawsuit, filed Aug. 9 in federal court, comes two days after similar allegations were levied against CVS Health Corp. The pharmacies are accused of charging customers with health insurance more for generic drugs than they would pay without insurance. The customer suing Walgreens says he was required to pay nearly $22 for a drug that would have cost him only $10 ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.